Yang Xiaohan, Shen Xinyue, Li Zhujun, Li Wencai, Liu Ying
Department of Pathology, School of Basic Medical Sciences, Fudan University, 138 Yi Xue Yuan Road, Shanghai, 200032 People's Republic of China.
Department of Pathology, The First Affiliated Hospital of Zhengzhou University, 1st Jianshe East Road, Zhengzhou, 450052 Henan People's Republic of China.
3 Biotech. 2021 Nov;11(11):486. doi: 10.1007/s13205-021-03028-8. Epub 2021 Nov 1.
Tumor genome methylation is closely related to tumor immunosuppression. In the present study, we evaluated the fluctuations in DNA methylation levels, and the numbers of infiltrating T cells and their cytokines in different-grade cervical lesions. A total of 154 human cervical specimens that included LSIL (43 cases), HSIL (48 cases), and cervical squamous cancer (63 cases) were used for this study. Immunohistochemistry for 5-hydroxymethylcytosine (5hmC) and T-cell-attracting chemokines was performed, and multiplex immunofluorescence labeling was used to identify different T-cell subtypes. We found that the proportions of samples that immunostained weakly or negatively for 5hmC were increased commensurately with elevations in the severity of cervical lesions. The expression of T-cell-attracting chemokines-including CXCL9, CXCL10, and CXCL11-was positively associated with 5hmC levels, and CXCL9 was the cytokine that was most pronounced. With the progression of cervical lesions, the numbers of total T cells, CTL, and NK cells in the cervical tissues all gradually decreased. During the occurrence and development of cervical squamous carcinoma, 5hmC was gradually lost, and immunosuppression occurred in precancerous cervical lesions.
肿瘤基因组甲基化与肿瘤免疫抑制密切相关。在本研究中,我们评估了不同级别宫颈病变中DNA甲基化水平的波动、浸润性T细胞的数量及其细胞因子。本研究共使用了154例人类宫颈标本,包括低级别鳞状上皮内病变(LSIL,43例)、高级别鳞状上皮内病变(HSIL,48例)和宫颈鳞癌(63例)。进行了5-羟甲基胞嘧啶(5hmC)和T细胞趋化因子的免疫组织化学检测,并采用多重免疫荧光标记来识别不同的T细胞亚型。我们发现,5hmC免疫染色弱阳性或阴性的样本比例随着宫颈病变严重程度的升高而相应增加。包括CXCL9、CXCL10和CXCL11在内的T细胞趋化因子的表达与5hmC水平呈正相关,且CXCL9是最为显著的细胞因子。随着宫颈病变的进展,宫颈组织中总T细胞、细胞毒性T淋巴细胞(CTL)和自然杀伤细胞(NK细胞)的数量均逐渐减少。在宫颈鳞癌的发生发展过程中,5hmC逐渐丢失,且宫颈癌前病变中出现免疫抑制。